Prospectively, pharmacist is a good career

ATHINA - drug therapy safety in pharmacies

Abstract I-02
5th German Congress for Patient Safety in Drug Therapy; Berlin, 18. – 19. October 2018

C. John1, J. Fabricius2, J. Hauser3, I. Justus4, P. Schäfer5, H. Seidling6

1Chamber of Pharmacists North Rhine AMTS / ATHINA, Poststr. 4, 40213 Düsseldorf, Germany
2Chamber of Pharmacists Lower Saxony Advanced Training, An der Markuskirche 4, 30163 Hannover, Germany
3Landesapothekerkammer Hessen, Kuhwaldstrasse 46, 60486 Frankfurt am Main, Germany
4Bremen Chamber of Pharmacists, Eduard-Grunow-Strasse 11, 28203 Bremen, Germany
5State Chamber of Pharmacists Baden-Württemberg, Villastrasse 1, 70190 Stuttgart, Germany
6Heidelberg University Hospital Cooperation Unit Clinical Pharmacology / Clinical Pharmacology and Pharmacoepidemiology, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany

ATHINA - drug therapy safety in pharmacies

Medication analyzes are a promising approach to identify problems in medication and to solve them in the short term. So far, only limited information is available on the practicability and importance of systematic medication analyzes for daily work in the public pharmacy.


In the pharmacy-centered project ATHINA, initiated by the pharmacy chambers of North Rhine, Lower Saxony, Baden-Württemberg, Hesse and Bremen, trained pharmacists offer medication analyzes for older patients with polypharmacy. More than 2000 pharmacists have been trained since 2012 and regularly offer medication analyzes.


In a retrospective analysis, 912 medication analyzes with an average of 10.8 ± 3.6 drugs were evaluated by a total of 241 ATHINA pharmacists. The pharmacists documented at least one drug-related problem in almost every patient (N = 869/912, 95.3%). In 75.7% (N = 3972/5248) of the drugs with an ABP or information requirement, the pharmacists documented the measures that were taken to solve the problem.

In the end, the pharmacists stated that 60.9% of the problems were solved, 22.7% partially solved and 5.5% could actually be assessed as no problem at all. On average, the rate of problematic drugs per medication decreased from 56 ± 22.7% to 28.9 ± 18.3% and, conversely, the proportion of patients whose medication no longer contained a single (unresolved) ABP rose significantly 39.4% (compared with 4.7% of the patients in whom not a single ABP was identified in the medication at the beginning of the analysis, p <>

Discussion and Conclusions

This analysis shows that pharmacists in public pharmacies are very good at identifying patients who have drug-related problems or need information about their medication. Pharmacists can solve many of these problems with a medication analysis.

In order to evaluate the medium-term influence of an ATHINA intervention on medication and patient-related endpoints, the ATHINA consortium is currently conducting a prospective study - the first results will be available in the second half of 2018.


Seidling HM, Send AF, Bittmann J, Renner K, Dewald B, Lange D, Bruckner T, Haefeli WE. Medication review in German community pharmacies - Post-hoc analysis of documented drug-related problems and subsequent interventions in the ATHINA project. Res Social Adm Pharm 2016 (Epub). doi: 10.1016 / j.sapharm.2016.10.016

Conflicts of Interest

The authors deny a conflict of interest.

PDF download of this article